These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31600630)

  • 1. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 3. Six policy lessons relevant to cannabis legalization.
    Shover CL; Humphreys K
    Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
    [No Abstract]   [Full Text] [Related]  

  • 4. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic Differences in Cannabis Conversations on Twitter: Infodemiology Study.
    van Draanen J; Tao H; Gupta S; Liu S
    JMIR Public Health Surveill; 2020 Oct; 6(4):e18540. PubMed ID: 33016888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California.
    Silver LD; Naprawa AZ; Padon AA
    JAMA Netw Open; 2020 Jun; 3(6):e208393. PubMed ID: 32558915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
    Shi Y; Liang D
    Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Where does the high road lead?" Potential implications of cannabis legalization for pediatric injuries in Canada.
    Karbakhsh M; Smith J; Pike I
    Can J Public Health; 2018 Dec; 109(5-6):752-755. PubMed ID: 30264194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.
    Myran DT; Brown CRL; Tanuseputro P
    CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critique of cannabis legalization proposals in Canada.
    Kalant H
    Int J Drug Policy; 2016 Aug; 34():5-10. PubMed ID: 27292414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. County-Level Recreational Marijuana Policies and Local Policy Changes in Colorado and Washington State (2012-2019).
    Payán DD; Brown P; Song AV
    Milbank Q; 2021 Dec; 99(4):1132-1161. PubMed ID: 34407252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting the public from exposure to secondhand cannabis smoke and vapour following legalization.
    McKee G; McClure S; Fyfe M; Stanwick R
    Can J Public Health; 2018 Apr; 109(2):223-226. PubMed ID: 29981035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic.
    Roth W; Tam M; Bi C; Kim J; Lewis J; Ho R; Apollonio DE
    Clin Toxicol (Phila); 2022 May; 60(5):632-638. PubMed ID: 34871128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America.
    Goundar P; Macaulay T; Szafron M
    Int J Drug Policy; 2021 Aug; 94():103191. PubMed ID: 33756442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of "home" cultivation policies and the case for community-based cannabis supply.
    Belackova V; Roubalova Stefunkova M; van de Ven K
    Int J Drug Policy; 2019 Sep; 71():36-46. PubMed ID: 31200326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.